ABDXF (Abingdon Health) Quick Ratio: 1.73 (As of Dec. 2025) — Near Median


ABDXF Abingdon Health PLC ABDXF
49 GF Score
Price $0.15
GF Value $0.21
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Abingdon Health Quick Ratio?

Abingdon Health ABDXF +8.93% 49 Quick Ratio is 1.73 as of Dec. 2025, which is 6% below its 10-year median of 1.85. GuruFocus rates ABDXF with a GF Score™ of 49/100 and a GF Value™ of $0.21 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Abingdon Health ranks better than 51.16% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Abingdon Health's quick ratio for the quarter that ended in Dec. 2025 was 1.73.

Abingdon Health has a quick ratio of 1.73. It generally indicates good short-term financial strength.

The historical rank and industry rank for Abingdon Health's Quick Ratio or its related term are showing as below:

ABDXF' s Quick Ratio Range Over the Past 10 Years
Min: 0.92   Med: 1.85   Max: 2.78
Current: 1.73

During the past 8 years, Abingdon Health's highest Quick Ratio was 2.78. The lowest was 0.92. And the median was 1.85.

ABDXF's Quick Ratio is ranked better than
51.16% of 215 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.67 vs ABDXF: 1.73

Abingdon Health  (OTCPK:ABDXF) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Abingdon Health Quick Ratio Related Terms


Abingdon Health Quick Ratio Historical Data

* Premium members only.

The historical data trend for Abingdon Health's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abingdon Health Quick Ratio Chart

Abingdon Health Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Quick Ratio
Get a 7-Day Free Trial 1.40 1.96 2.09 1.70 1.58

Abingdon Health Semi-Annual Data
Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.59 1.70 2.36 1.58 1.73

ABDXF vs TMO, DHR, IDXX: Quick Ratio Comparison

For the Diagnostics & Research subindustry, Abingdon Health's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abingdon Health Quick Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Abingdon Health's Quick Ratio falls into.


ABDXF
49GF Score
Abingdon Health PLC ABDXF
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abingdon Health Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Abingdon Health's Quick Ratio for the fiscal year that ended in Jun. 2025 is calculated as

Quick Ratio (A: Jun. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(6.961-0.714)/3.961
=1.58

Abingdon Health's Quick Ratio for the quarter that ended in Dec. 2025 is calculated as

Quick Ratio (Q: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(8.967-0.854)/4.687
=1.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 1.73 mean?
Abingdon Health (ABDXF) has a Quick Ratio of 1.73 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Abingdon Health and its competitors. This is near median its historical median of 1.85. Over the past decade, Abingdon Health's Quick Ratio has ranged from 0.92 to 2.78. According to the industry distribution chart, Abingdon Health ranks #105 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 48.8%.
Is Abingdon Health's Quick Ratio too high?
Abingdon Health's current Quick Ratio of 1.73 is near median its 10-year median of 1.85. Over the past 10 years, this metric has ranged from a low of 0.92 to a high of 2.78. The Medical Diagnostics & Research industry median Quick Ratio is 1.67. Abingdon Health's value of 1.73 is 3.6% above this industry median. Based on the distribution chart, Abingdon Health ranks #105 out of 215 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Abingdon Health has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abingdon Health's Quick Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Abingdon Health ranks #105 out of 215 companies for Quick Ratio. This puts Abingdon Health in the upper half of its industry. The industry median Quick Ratio is 1.67. Abingdon Health's value of 1.73 is 3.6% above this benchmark. Historically, Abingdon Health's own Quick Ratio has ranged from 0.92 to 2.78 over the past decade. While the company's 10-year median is 1.85 vs. the industry median of 1.67, Abingdon Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.67, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abingdon Health's current Quick Ratio of 1.73 is 3.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Abingdon Health and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abingdon Health's current Quick Ratio is 1.73, which is near median its own 10-year median of 1.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abingdon Health stock overvalued right now?
Based on GuruFocus' analysis, Abingdon Health (ABDXF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.21, compared to a current price of $0.15 — trading 27.4% below its estimated fair value. The current Quick Ratio is 1.73, which is near median its 10-year median of 1.85 and 3.6% above the Medical Diagnostics & Research industry median of 1.67. Abingdon Health's overall GF Score™ is 49/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Abingdon Health (ABDXF), the current Quick Ratio is 1.73 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abingdon Health (ABDXF) Overvalued in 2026?

Based on GuruFocus' analysis, Abingdon Health stock appears to be undervalued. The current stock price of $0.15 is trading 27.4% below its estimated GF Value™ of $0.21. GuruFocus considers Abingdon Health to be Modestly Undervalued.

Key valuation signals for ABDXF:

  • Quick Ratio: 1.73 (near median its 10-year median of 1.85)
  • GF Value™: $0.21 vs. price of $0.15 (27.4% below fair value)
  • GF Score™: 49/100 with 9 warning signs
  • Industry Position: 3.6% above the Medical Diagnostics & Research median (#105 of 215)

No single metric tells the full story. See the ABDXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abingdon Health Business Description

Other Exchanges ABDX:UK
Address York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC develops, manufactures, and distributes diagnostic devices and provides regulatory consultancy to diagnostics businesses. It offers integrated lateral flow CRO/CDMO services covering feasibility, manufacturing, packaging, kitting, documentation, and commercial support. Segments include Contract Development (milestone-based third-party work, revenue over time by completion), Contract Manufacturing (development/manufacturing via daily consultancy, revenue at customer control point), Product Sales (AbC-19TM, Pocket Diagnostic, PCRD tests, research antibodies, carriage; point in time), and Regulatory Services (IVD/medical device compliance, revenue over time), with key revenue from Regulatory Services. It operates in the UK, USA/Canada, Europe, and rest of world.
49GF Score

Get the complete analysis for ABDXF

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price
$0.21
GF Value